| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |